Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
18 hedge funds and large institutions have $4.83M invested in Biocept, Inc. in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 8 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
2.27% less ownership
Funds ownership: 10.45% → 8.18% (-2.3%)
10% less funds holding
Funds holding: 20 → 18 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
50% less capital invested
Capital invested by funds: $9.75M → $4.83M (-$4.92M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
+$562K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$369K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$106K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.1K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$33.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$2.48M |
| 2 |
BlackRock
New York
|
-$390K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$26K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$18.6K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$18K |
BIOC Hedge Fund Activity: Q3 2020 in Review
18 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q3 2020, worth a combined $4.83M — down 50% from $9.75M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of BIOC and 6 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 5 added.
The largest buyer was Hussman Strategic Advisors, opening a new position worth an estimated $562K. The largest seller was Renaissance Technologies, cutting an estimated $2.48M.
- 18 institutional investors held Biocept, Inc. (BIOC) as of Q3 2020, down from 20 in Q2 2020.
- Funds reported $4.83M of Biocept, Inc. stock for Q3 2020, down 50% quarter-over-quarter.
- 6 funds opened new Biocept, Inc. positions in Q3 2020 and 8 closed out, a net change of -2 holders.
- The largest Biocept, Inc. buyer in Q3 2020 was Hussman Strategic Advisors, an estimated $562K added.
- The largest Biocept, Inc. seller in Q3 2020 was Renaissance Technologies, an estimated $2.48M sold.
Based on aggregated 13F filings for Q3 2020.